fbpx
QQQ
+ 3.08
328.44
+ 0.93%
DIA
+ 2.59
342.95
+ 0.75%
SPY
+ 3.37
415.73
+ 0.8%
TLT
-0.97
140.89
-0.69%
GLD
+ 1.48
168.57
+ 0.87%

Friends of Benzinga

Citron’s Andrew Left Says GameStop Is ‘Pretty Much In Terminal Decline’

Citron Research editor and notorious short seller Andrew Left joined Benzinga’s ZingerNation Power Hour Thursday to discuss his short thesis on GameStop Corp. (NYSE: GME). read more

Will Workhorse Or Electrameccanica Stock Grow More By 2022?

Every week, Benzinga conducts a sentiment survey to find out what traders are most excited about, interested in or thinking about as they manage and build their personal portfolios. read more

The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 20) read more

SPACs Attack Recap: SoFi, IPOE, GXGX, ACEV Deals Plus Rumors And Headlines For Week Ending January 8

The SPACs Attack show airs live on Benzinga YouTube Monday through Friday at 11 a.m. EST breaking down SPAC news and deals, and interviewing CEOs. Here is a look back at some of the important SPAC news for the week ending January 8. read more

The Daily Biotech Pulse: Fluidigm’s Saliva-Based COVID Test Approved In Europe, China Backs Amarin’s Vascepa

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) read more